Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2180
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic ; volume:18 ; number:1 ; day:22 ; month:3 ; year:2018 ; pages:1-8 ; date:12.2018
BMC microbiology ; 18, Heft 1 (22.3.2018), 1-8, 12.2018
- Creator
-
Isakova, Jainagul
- Contributor
-
Sovkhozova, Nurmira
Vinnikov, Denis
Goncharova, Zoy
Talaibekova, Elnura
Aldasheva, Nazira
Aldashev, Almaz
SpringerLink (Online service)
- DOI
-
10.1186/s12866-018-1168-x
- URN
-
urn:nbn:de:1111-201805267828
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Isakova, Jainagul
- Sovkhozova, Nurmira
- Vinnikov, Denis
- Goncharova, Zoy
- Talaibekova, Elnura
- Aldasheva, Nazira
- Aldashev, Almaz
- SpringerLink (Online service)
Other Objects (12)
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)